A case of conventional treatment failure in visceral leishmaniasis: leukocyte distribution and cytokine expression in splenic compartments
Carregando...
Citações na Scopus
13
Tipo de produção
article
Data de publicação
2014
Editora
BIOMED CENTRAL LTD
Indexadores
Título da Revista
ISSN da Revista
Título do Volume
Autores
DOS-SANTOS, Washington L. C.
SANTOS, Lina G.
ALMEIDA, Valter A.
SILVA, Thiago L. V. e
COUTINHO JR., Joao de J.
SOUZA, Tulio
FREITAS, Luiz A. R. de
COSTA, Carlos H. N.
Autor de Grupo de pesquisa
Editores
Coordenadores
Organizadores
Citação
BMC INFECTIOUS DISEASES, v.14, article ID 491, 7p, 2014
Resumo
Background: In this paper we study the distribution of leukocyte populations and of cytokine-producing cells in the spleen of a patient with visceral leishmaniasis resistant to clinical treatment. It is the first attempt to compare the distribution of leukocyte populations and cytokine-producing cells in the splenic compartments of a patient with visceral leishmaniasis with those observed in patients without the disease. Case presentation: A 25-year-old male, farmer, was hospitalized on several occasions with diagnosis of visceral leishmaniasis and received all recommended treatments for the disease with only transient improvement followed by relapse. He was eventually subjected to splenectomy in order to control the effects of hypersplenism and to potentially overcome infection. After surgery and combined chemotherapy, the disease evolved to cure. In comparison with the spleens of the other two patients without visceral leishmaniasis, an increase was observed in the CD4/CD8 ratio and in the number of IL-10- and FoxP3-producing cells, while the number of IL-17-producing cells was lower in the spleen of the patient with visceral leishmaniasis. Conclusion: This report confirms previous data on changes in the CD4/CD8 ratio in the spleens of patients with visceral leishmaniasis. Additionally the data presented herein suggests that splenic FoxP3- and IL-17-producing cells are involved in the chronicity of visceral leishmaniasis.
Palavras-chave
Visceral leishmaniasis, Spleen, Cytokines, Leukocyte populations, Leishmania infantum, Leishmania chagasi
Referências
- Alvar J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035671
- ANDRADE ZILTON A., 1966, REV INST MED TROP SAO PAULO, V8, P259
- Costa CHN, 2010, REV SOC BRAS MED TRO, V43, P386, DOI 10.1590/S0037-86822010000400010
- Dutra RA, 2012, REV SOC BRAS MED TRO, V45, P130, DOI 10.1590/S0037-86822012000100027
- Froes AM, 2004, VET IMMUNOL IMMUNOP, V99, P135, DOI 10.1016/j.vetimm.2004.01.013
- Ghosh K, 2013, J INFECT DIS, V207, P1016, DOI 10.1093/infdis/jis771
- Gu CF, 2013, CYTOKINE, V64, P477, DOI 10.1016/j.cyto.2013.07.022
- Nylen S, 2007, J EXP MED
- Olliaro PL, 2005, LANCET INFECT DIS, V5, P763, DOI 10.1016/S1473-3099(05)70296-6
- Pitta MGR, 2009, J CLIN INVEST, V119, P2379, DOI 10.1172/JCI38813
- Troya J, 2007, PARASITOLOGY, V134, P621, DOI 10.1017/S0031182006002058
- Wilkins BS, 2000, ILLUSTRATED PATHOLOG